Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
9/19/2023
CDE Solicits Comments for the Latest Adjustment Catalog of Reference F...
9/12/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Study o...
9/12/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Study o...
9/12/2023
China Adjusts the Catalog of Narcotic and Psychotropic Drugs
9/7/2023
CDE Releases the Annual Report on New Drug Registration Clinical Trial...
9/6/2023
NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
9/5/2023
NMPA Issues Announcement for Applicability of ICH Guidelines Q9(R1)
9/5/2023
NMPA Issues the Announcement for Applicability of ICH Guidelines S12
9/4/2023
CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
9/1/2023
CDE Solicits Comments on the Technical Guidelines for Post-Marketing P...
8/31/2023
NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
8/30/2023
CDE Publicizes the List of Reference Formulations for GQCE Studies (73...
8/29/2023
NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...
8/29/2023
NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
8/29/2023
NMPA Announces Package Insert Revision of Two Drug Products
8/28/2023
CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...
8/25/2023
NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
8/25/2023
NMPA Issues Announcement for Applicability of ICH Guidelines Q12
8/25/2023
CDE Seeks Comments on Draft ICH Guidelines M7(R2)
8/23/2023
NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
8/22/2023
CDE Solicits Comments on Bioequivalence Study Guidelines of Six Generi...
8/17/2023
NMPA Revises the Information Standard System for Drug Regulatory Digit...
8/17/2023
NMPA Issues the List of Reference Formulations for GQCE Studies (71st ...
8/17/2023
NMPA Announces Package Insert Revision of Three Drug Products
8/15/2023
NHC Releases Q&A Document to Highlight/Clarify Focused Areas of Health...
8/9/2023
China Intensifies Efforts to Combat Healthcare Corruption
8/7/2023
Crackdown on Chinese Pharma Irregularities Disrupts Medical Conference...
8/7/2023
NMPA Holds Meeting to Promote Construction of Drug Regulation Quality ...
8/1/2023
CDE Solicits Comments over the Technical Guidelines on Pharmacokinetic...
8/1/2023
Review of New Drugs Approved in China H1/2023
Page:
6
/
9
Total number of articles:
250
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit